Bill Text: OR HB2462 | 2011 | Regular Session | Introduced

---

Bill Title: Relating to controlled substances; declaring an emergency.

Spectrum: Bipartisan Bill

Status: (Failed) 2011-06-30 - In committee upon adjournment. [HB2462 Detail]

Download: Oregon-2011-HB2462-Introduced.html

---

     76th OREGON LEGISLATIVE ASSEMBLY--2011 Regular Session

NOTE:  Matter within  { +  braces and plus signs + } in an
amended section is new. Matter within  { -  braces and minus
signs - } is existing law to be omitted. New sections are within
 { +  braces and plus signs + } .

LC 1417

                         House Bill 2462

Sponsored by Representatives GELSER, THOMPSON, OLSON, Senator
  MORSE; Representatives DOHERTY, TOMEI (Presession filed.)

                             SUMMARY

The following summary is not prepared by the sponsors of the
measure and is not a part of the body thereof subject to
consideration by the Legislative Assembly. It is an editor's
brief statement of the essential features of the measure as
introduced.

  Directs State Board of Pharmacy to classify certain synthetic
cannabinoid compounds as Schedule I controlled substances.
  Declares emergency, effective on passage.

                        A BILL FOR AN ACT
Relating to controlled substances; and declaring an emergency.
Be It Enacted by the People of the State of Oregon:
  SECTION 1.  { + The State Board of Pharmacy shall classify as a
controlled substance in Schedule I the following substances,
including their isomers, homologues, esters, ethers, salts and
salts of isomers, esters and ethers, except when in the
possession of a manufacturer or research facility registered with
the federal Food and Drug Administration, or of a person for the
purpose of sale to a manufacturer or research facility registered
with the federal Food and Drug Administration:
  (1) CP 47,497 and homologues:  2- (1R,3S)-3-hydroxycyclohexyl
-5-(2-methyloctan-2-yl)phenol).
  (2) HU-210:

(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2methyloctan-2-yl)-?
6a,7,10,10a-tetrahydrobenzo c chromen-1-o1) , also known as
6aR-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy?
-6,6-dimethyl-6H-dibenzo b,d pyran-9-methanol.
  (3) JWH-018: 1-pentyl-3-(1-naphthoyl)indole, also known as
Naphthalen-1-yl-(1-pentylindol-3-yl)methanone.
  (4) JWH-073: 1-butyl-3-(1-naphthoyl)indole, also known as
Naphthalen-1-yl-(1-butylindol-3-yl)methanone.
  (5) JWH-200:  1- 2-(4-morpholinyl)ethyl -3-(1-naphthoyl)indole.
  (6) JWH-081: 1-pentyl-3-(4-methoxy-1-naphthoyl)indole, also
known as 4-methoxynaphthalen-1-yl- (1-pentylindol-3-yl)methanone.
  (7) JWH-250: 1-pentyl-3-(2-methoxyphenylacetyl)indole, also
known as 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone.
  (8) Any other cannabinoid receptor agonist that is not listed
in Schedules II to V or is not a drug approved by the federal
Food and Drug Administration. + }
  SECTION 2.  { + This 2011 Act being necessary for the immediate
preservation of the public peace, health and safety, an emergency
is declared to exist, and this 2011 Act takes effect on its
passage. + }
                         ----------

DSMW32708E TEXT EXCEEDS RIGHT PAGE BOUNDARY ON PAGE 1.